This impact corresponds to the project objectives (Strengthening excellence of SU in the field of EE, capacity building of SU in the field of Next Generation Sequencing Technologies). EE is a large group of epilepsy syndromes. Besides well...
Read more
Improve skills in the electro-clinical diagnostic will allow SU to better delineated other epileptic syndromes in children. The increased technical capacity in NGS will allow SU to develop its panel design and to use their acquired skills in...
Read more
SEED results will lead all the partners and especially the coordinating group, to determine new specific electro-clinical syndromes and new gene abnormalities, thereby increasing its recognition reputation and allowing them to: participate...
Read more
The expertise acquired by SU members during the H2020 project will help them becoming more competitive in national call for research budget e.g federate research project (PRF) and VRR. European partners have a strong experience in multinational...
Read more
SEED project will result in quantitative and qualitative impact (see also table 2). Quantitative impact in research and innovation capacity: Decrease the delay of electro-clinical diagnosis (from 4 to 2 months) Decrease the number of non...
Read more
Early and precise electro-clinical and genetic diagnosis (WP3 & WP4) will diminish the delay and allow patients to receive adapted medicine and care and families to have access to genetic counseling. Through education programs for parents and...
Read more
Through the SEED project, we ambition to have a positive economic impact on the cost of the EE diagnosis odyssey and its three components: Cost of time lost to patient/family: the time between electro-clinical diagnosis for EE syndromes and the...
Read more
The current Tunisian and European legislative framework is poorly dapted to these diseases.SEED will provide timely data about the health costs and seek to develop strong links with the relevant decision-makers and public authorities, Tunisian...
Read more